Khattar Jack A.
- SEC CIK
- 0001539937
In the past year, 6 open-market sale filings worth $7.72M and no purchases.
Current role at each company
- SUPN Supernus Pharmaceuticals, Inc.President, CEOas of Aug 14, 2026
- CGTX Cognition Therapeutics IncDirectoras of Jun 22, 2026
- SCPH scPharmaceuticals Inc.Directoras of Oct 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.72M
- 6 filings
- Net
- −$7.72M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Khattar Jack A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SUPN Supernus Pharmaceuticals, Inc.
President, CEO32 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 (view filing) | Mar 13 | 3 days | Khattar Jack A.President, CEO | SSale | −35.0K | $50.37 | −$1.76M | −3.5%958.1K after | 3 lots10b5-1 |
| Oct 10, 2025 (view filing) | Oct 9 | 1 day | Khattar Jack A.President, CEO | SSale | −59.9K | $50.57 | −$3.03M | −4.7%1.21M after | 2 lots10b5-1 |
| Oct 3, 2025 (view filing) | Oct 2 | 1 day | Khattar Jack A.President, CEO | SSale | −1.90K | $48.06 | −$91.5K | −0.2%1.16M after | 10b5-1 |
| Oct 2, 2025 (view filing) | Oct 1 | 1 day | Khattar Jack A.President, CEO | SSale | −40.2K | $48.07 | −$1.93M | −3.3%1.16M after | 10b5-1 |
| Oct 1, 2025 (view filing) | Sep 30 | 1 day | Khattar Jack A.President, CEO | SSale | −8.59K | $48.25 | −$414.4K | −0.7%1.15M after | 10b5-1 |
| Sep 30, 2025 (view filing) | Sep 29 | 1 day | Khattar Jack A.President, CEO | SSale | −10.2K | $48.02 | −$491.5K | −0.9%1.14M after | 10b5-1 |
| Sep 24, 2025 (view filing) | Sep 23 | 1 day | Khattar Jack A.President, CEO | SSale | −29.5K | $47.23 | −$1.39M | −2.5%1.14M after | 10b5-1 |
| Sep 23, 2025 (view filing) | Sep 22 | 1 day | Khattar Jack A.President, CEO | SSale | −16.6K | $47.02 | −$779.9K | −1.5%1.12M after | 10b5-1 |
| Sep 9, 2025 (view filing) | Sep 8 | 1 day | Khattar Jack A.President, CEO | SSale | −6.32K | $46.29 | −$292.6K | −0.6%1.11M after | 10b5-1 |
| Sep 8, 2025 (view filing) | Sep 5 | 3 days | Khattar Jack A.President, CEO | SSale | −55.6K | $46.01 | −$2.56M | −4.8%1.11M after | 10b5-1 |
SCPH scPharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Khattar Jack A.Director | PPurchase | +5.00K | $3.91 | +$19.6K | New position5.00K after |